reference/17316017

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17316017

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1541
issn	0026-895X 1521-0111
issueIdentifier	5
pageRange	1534-1541
publicationName	Molecular Pharmacology
startingPage	1534
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_620f67b9f3828c6c814dafd46d47ea93
bibliographicCitation	Tseng PH, Wang YC, Weng SC, Weng JR, Chen CS, Brueggemeier RW, Shapiro CL, Chen CY, Dunn SE, Pollak M, Chen CS. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor. Mol Pharmacol. 2006 Nov;70(5):1534–41. doi: 10.1124/mol.106.023911. PMID: 16887935.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58afe0df811de927e69b6f54103bc577 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0ee62f743b46f44ce5e1678fa68d074 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4995e23a625e194d9cc3262ec6531323 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f356f6db642d2adb9684c042bc4a0865 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81b941425c635a7370ce222ec83bea46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5fe3adebf08417c4126329d3deca4b1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e108995ae9b67b01e7868f152af14422 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb1d79add86ada5b51a0a16352bb587d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd85ad6866208e4407f0550e894e95dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b47cd8c850ad56ff1dfa02ead38a4bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4095-4197 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99ac8695188672ef04be9c4a4b3d4d0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3047-0604
date	2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1124/mol.106.023911 https://pubmed.ncbi.nlm.nih.gov/16887935
isPartOf	https://portal.issn.org/resource/ISSN/1521-0111 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5912 https://portal.issn.org/resource/ISSN/0026-895X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor
discusses	http://id.nlm.nih.gov/mesh/M0203045 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0026587 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0291428 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0026339 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0581691 http://id.nlm.nih.gov/mesh/M0276185 http://id.nlm.nih.gov/mesh/M0485490
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000911Q000494 http://id.nlm.nih.gov/mesh/D013449Q000494 http://id.nlm.nih.gov/mesh/D017346Q000037 http://id.nlm.nih.gov/mesh/D011720Q000494 http://id.nlm.nih.gov/mesh/D018719Q000378 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D001943Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068878 http://id.nlm.nih.gov/mesh/D004354 http://id.nlm.nih.gov/mesh/D017526Q000378 http://id.nlm.nih.gov/mesh/D051057Q000378 http://id.nlm.nih.gov/mesh/D050760Q000378 http://id.nlm.nih.gov/mesh/D000971 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D064413 http://id.nlm.nih.gov/mesh/D010766Q000187 http://id.nlm.nih.gov/mesh/D015870 http://id.nlm.nih.gov/mesh/D015854Q000187 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D010641 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D000068579 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_00018f81c30c51bce348eb37edf93cc0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cbea4e87c048f40098c32e658cbcbe76 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_14cc0ec19bef89e93f5b9dd7ed31f321 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b30b0b608593935259123d48ab1a931d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6600c5cd2493e3a8f413e3b3388d00c7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25e7482d087cb6429609f07a507aa159 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2e9bca9c913bd9716f919e72d3912159 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7826c784e8fc911de47e7fb31a96992f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b8b61580f3b0744d9098586a01c34cc3 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3da33ba6cc57d9bd47a91ecc7cb7ba07 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10027278 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_42e5c8717e13ca9e92807498eccbf953 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2c7bb8c933bedf612fa484b24eb8abd1

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247295286 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129202881 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5170

Total number of triples: 99.